Picture of Biomx logo

PHGE Biomx Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Annual cashflow statement for Biomx, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-36.2-28.3-26.2-17.7-36.2
Depreciation
Non-Cash Items2.981.131.54-18.16.91
Unusual Items
Other Non-Cash Items
Changes in Working Capital3.1-4.432.48-2.99-0.023
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-27.6-29.1-21.3-37-26.4
Capital Expenditures-3.68-0.112-0.05-0.03-0.002
Purchase of Fixed Assets
Other Investing Cash Flow Items19.9-220.7450.11
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Cash from Investing Activities16.2-2.111.950.7150.108
Financing Cash Flow Items-0.33320.4-0.118
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities37.30.2922.938.413.2
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash25.9-30.8-16.42.11-13